ShareValue scores for ROSE.BA: Valuation 49, Quality 29, Growth 44, Health 41.

ROSE.BA
BYMA

Instituto Rosenbusch S.A.

ARS 160.50(+0.31%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

5% to 17%
Valuation
49
Fair Value
Price vs Value
Quality
29
Weak
Business Strength
Growth
44
Moderate
Revenue & Earnings
Health
41
Moderate
Financial Stability
Momentum
36
Bearish
Price Trend

Company Details

About

Instituto Rosenbusch S.A. manufactures and sells veterinary products in Argentina. The company offers biological products, including products for reproductive-respiratory complex, IBR, BVD, brucelosis, carbuncle, and other diseases; clostridial vaccines; vaccines for cattle, sheep, goats, horses, and dogs; and products for the prevention of pneumonia and calve diarrhea, and cattle infectious keratoconjunctivitis. It also provides pharmaceutical products, such as external and internal antiparasitics, endectocides, antimicotics-bacteriostatics, injectable antibiotics, antimastitics, and other chemotherapics, as well as vitamins and minerals. The company was founded in 1917 and is based in Buenos Aires, Argentina.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026